Clinical trials: Double-Embryo Transfer in ICSI
Infertility, Female, Infertility
Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes.
The main objective of this clinical research trial is to test the efficacy of OXO-001 in a daily oral administration increasing the pregnancy rate in IVF/ICSI by preparing the uterus to receive the embryo.
- Trial name
- OXOART2 (NCT05076032)
- Testing
- OXO-001
- Where
- 28 sites in Czechia, Poland and 1 more
- Volunteers
- 408 people
- Sponsor
- OXOLIFE
Polycystic Ovary Syndrome
Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients
The purpose of this study is to determine whether simvastatin is effective in the improvement of IVF-ICSI outcome in Pcos patients.
- Trial name
- NCT00575601
- Testing
- SIMVASTATIN
- Where
- Iran
- Volunteers
- 120 people
- Sponsor
- Tehran University of Medical Sciences
IVF, Intracytoplasmic Sperm Injection
Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.
- Trial name
- NCT04751084
- Testing
- Buscopan 20 milligrams/ML Injectable Solution
- Where
- Hong Kong
- Volunteers
- 675 people
- Sponsor
- Chinese University of Hong Kong
Infertility
OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI
The primary objective of this study is to assess the increase in clinical pregnancy rate after administration of a range of single oral doses of OBE001, an oral oxytocin antagonist, compared to placebo.
- Trial name
- IMPLANT (NCT02310802)
- Testing
- OBE001 dose 1, OBE001 dose 2, OBE001 dose 3
- Where
- 18 sites in Belgium, Czechia and 4 more
- Volunteers
- 247 people
- Sponsor
- ObsEva SA
Double-Embryo Transfer in ICSI
Obstetric Outcomes After Double Embryo Transfer
Aim ; to compare obstetric outcomes in relation to number of embryo transfer in ICSI
- Trial name
- NCT05322278
- Testing
- Data collection
- Where
- Egypt
- Volunteers
- 927 people, healthy volunteers welcome
- Sponsor
- Assiut University
Infertility
Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI
The primary objective of this study is to confirm the efficacy of a single oral 900mg dose of nolasiban to increase the ongoing clinical pregnancy rate at 10 weeks post embryo transfer (ET) day.
- Trial name
- IMPLANT2 (NCT03081208)
- Testing
- Nolasiban 900mg
- Where
- 43 sites in Belgium, Czechia and 7 more
- Volunteers
- 810 people
- Sponsor
- ObsEva SA